Lv11
66 积分 2023-09-27 加入
Immunedeconv: An R Package for Unified Access to Computational Methods for Estimating Immune Cell Fractions from Bulk RNA-Sequencing Data
1小时前
已完结
Alternative splicing generates HER2 isoform diversity underlying antibody–drug conjugate resistance in breast cancer
7天前
已完结
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial
7天前
已完结
Breast cancer genomic analyses reveal genes, mutations, and signaling networks
8天前
已完结
First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer
14天前
已完结
Advances and challenges of estrogen receptor-targeted agents in breast cancer
17天前
已完结
Systemic Therapy for Estrogen Receptor–Positive, HER2-Negative Breast Cancer
17天前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
22天前
已完结
Molecular Evidence of Multiorgan Damage in Patients with Immune-Related Adverse Events
23天前
已完结
Machine Learning–Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2– Early Breast Cancer Using Real-World and NATALEE Data
29天前
已完结
皖公网安备34019202002308
